3 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... Switching P2Y12 ... inhibitors during ... #plavix #antiplatelet ... ticagrelor #prasugrel #pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... oral agents in ... the timing and dosing ... #plavix #antiplatelet ... ticagrelor #prasugrel #pharmacology
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
: TOOL FOR SWITCHING ... BETWEEN AGENTS ... Doses should be ... ReceptorBlocker #Pharmacology ... #Conversion #Switching